Big Pharma vs. MedTech in Spain
Saturday, February 21, 2015
Source: Healthcare Global
Austerity measures implemented by the Spanish government have negated the effect of key drivers behind the country’s pharmaceutical market, resulting in a contracting market between 2008 and 2020, says research and consulting firm GlobalData.
However, the company’s latest report states that factors, such as an aging population and free health care service, will help drive an overall expansion of the country’s health care market over the next six years.